新股暗盤 | 譚仔國際(2217.HK)暗盤段跌4.8%
格隆匯10月6日丨據富途證券,譚仔國際(2217.HK)暗盤段現報3.17港元,較發行價3.33港元跌4.8%,總市值42.5億港元。公司是一家香港本地專營米線品類的休閒連鎖餐廳,2019年至2021年收益分別為15.56億、16.91億、17.94億港元,溢利分別為1.97億、1.91億、2.87億港元,每股有形資產淨值1.19-1.4港元,2021歷史市盈率15.51-19.42倍。公司此次上市全球發售3.35億股,其中香港發售1.005億股,國際發售2.34億股,每手1000股,一手中籤率7.14%,香港公開發售獲29.58倍認購,淨籌10.418億港元,當中約57.4%用於擴大餐廳網絡。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.